Current Value of Holding

$8.29 Million

Shares

97.9 Thousand

% of Portfolio

0.04%

Average Buy Price

$105

Avg closing price
Price range

18 Ray Dalio Dexcom Trades

Ray Dalio acquired 97.9 Thousand Dexcom shares worth $8.29 Million. That's 0.04% of their equity portfolio (274th largest holding). The first Dexcom trade was made in Q3 2020. Since then Ray Dalio bought shares eight more times and sold shares on nine occasions. The investor's estimated purchase price is $10.3 Million, resulting in a loss of 19%.

Avg closing price
Price range
Sold 69.4% shares (-222 Thousand shares) Q4 2024
Avg closing price $74.39
Price range $65.68 - $81.01
Sold 8.0% shares (-27.7 Thousand shares) Q3 2024
Avg closing price $82.36
Price range $64.00 - $116.06
Sold 6.3% shares (-23.5 Thousand shares) Q2 2024
Avg closing price $126.43
Price range $110.31 - $140.45
Sold 14.4% shares (-62.3 Thousand shares) Q1 2024
Avg closing price $125.70
Price range $114.22 - $140.10
Sold 28.0% shares (-168 Thousand shares) Q4 2023
Avg closing price $102.16
Price range $75.49 - $124.16
Increased shares by 43.8% (+183 Thousand shares) Q3 2023
Avg closing price $112.73
Price range $86.06 - $137.93
Sold 8.2% shares (-37.1 Thousand shares) Q2 2023
Avg closing price $120.95
Price range $112.47 - $130.98
Increased shares by 5.5% (+23.8 Thousand shares) Q1 2023
Avg closing price $111.94
Price range $104.00 - $122.92
Sold 30.8% shares (-192 Thousand shares) Q4 2022
Avg closing price $109.79
Price range $84.98 - $122.67
Sold 1.5% shares (-9.77 Thousand shares) Q3 2022
Avg closing price $84.70
Price range $76.35 - $94.18
Increased shares by 9.0% (+52.1 Thousand shares) Q2 2022
Avg closing price $91.26
Price range $67.99 - $132.89
Increased shares by 36.3% (+155 Thousand shares) Q1 2022
Avg closing price $109.39
Price range $94.08 - $130.20
Increased shares by 13.0% (+49.1 Thousand shares) Q4 2021
Avg closing price $143.69
Price range $129.87 - $162.82
Sold 10.6% shares (-44.6 Thousand shares) Q3 2021
Avg closing price $126.11
Price range $106.71 - $143.18
Increased shares by 188.5% (+276 Thousand shares) Q2 2021
Avg closing price $96.03
Price range $80.99 - $107.93
Increased shares by 12.3% (+16 Thousand shares) Q1 2021
Avg closing price $93.87
Price range $84.79 - $104.74
Increased shares by 86.7% (+60.4 Thousand shares) Q4 2020
Avg closing price $89.29
Price range $78.00 - $104.50
New holding (+69.7 Thousand shares) Q3 2020
Avg closing price $104.48
Price range $95.51 - $112.95

News about Dexcom Inc and Ray Dalio

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!